Form 8-K - Current report:
SEC Accession No. 0001140361-21-028904
Filing Date
2021-08-19
Accepted
2021-08-19 16:51:54
Documents
12
Period of Report
2021-08-18
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K brhc10028200_8k.htm   iXBRL 8-K 21143
  Complete submission text file 0001140361-21-028904.txt   159624

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA cycn-20210818.xsd EX-101.SCH 3926
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE cycn-20210818_lab.xml EX-101.LAB 23288
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cycn-20210818_pre.xml EX-101.PRE 16552
5 EXTRACTED XBRL INSTANCE DOCUMENT brhc10028200_8k_htm.xml XML 4223
Mailing Address 301 BINNEY STREET CAMBRIDGE MA 02142
Business Address 301 BINNEY STREET CAMBRIDGE MA 02142 617-621-7722
Cyclerion Therapeutics, Inc. (Filer) CIK: 0001755237 (see all company filings)

EIN.: 831895370 | State of Incorp.: MA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38787 | Film No.: 211190847
SIC: 2834 Pharmaceutical Preparations